University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 4 of 16
Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT
NCT06173375
Feasibility of Radiation-Free Percutaneus Nephrolithotomy for Kidney Stones
NCT06922006
Optimizing CBSST With Executive Function Training for Schizophrenia
NCT06251193
Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2A
NCT06314490
Impact of Progestin-only Contraception on Bleeding Patterns in Individuals Initiating GATT
NCT06230770
A Systems Analysis and Improvement Approach for Optimizing HIV Service Delivery in Syringe Services Programs
NCT06025435
Strong Foundations 2.0: A Digitally Delivered Fall Prevention Program.
NCT05910606
Impact of Neurochecks on Sleep in Critically Ill Adults
NCT05864300
Accurate Point of Care Liver Disease Diagnostics
NCT05986916
Environmental and Reproductive Health Risk for Lewy Body Dementia
NCT06005935
ADRB3 Signaling Pathway in Human Adipose Tissue
NCT05634174
"Bupe by the Book": A Tele-Buprenorphine Clinical Trial in Public Libraries With Unstably Housed Persons With Opioid Use Disorder
NCT05872386
The Effect of a Multi-strain Probiotic on Acclimatization to High Altitude
NCT06552806
Ketone Supplementation in Eating Disorders
NCT05507008
Family, Responsibility, Education, Support, and Health for Latino Caregivers (FRESH-LC)
NCT05437406
A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence
NCT05534412
Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention.
NCT05409651
Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa
NCT05368844
Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa
NCT04878627
Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL Patients
NCT04981912
Impact of Time Restricted Eating on Patients With Coronary Artery Disease (CAD) Undergoing Cardiac Rehabilitation
NCT05014880
Solutions for Hunger and Regulating Eating
NCT05004883
Effects of GRA in Patients With Type 1
NCT04779645
Meditation Accelerated Brain Stimulation for Depression
NCT04586699
TROLLEY Study - TRansit Opportunities for HeaLth, Livability, Exercise and EquitY
NCT04940481
Comparing Perioperative Outcomes in Pain Control
NCT05690282
Reflux Band in Laryngopharyngeal Reflux
NCT04827355
Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity
NCT04800159
Developing an EEG Paradigm to Study Prediction Error in Anorexia Nervosa
NCT04583774
Neurofeedback to Improve Working Memory in Mild Cognitive Impairment
NCT04566900
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)
NCT04349501
Effect of Time-restricted Eating on Catecholamine-sensitivity of Adipose Tissue in Obese Adults
NCT04916730
Tipping Point: Using Social Network Theory to Accelerate Scale and Impact
NCT05777473
Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
NCT04545710
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
NCT04501939
Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism
NCT04517799
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
NCT04616963
Improving Cognition After Cancer
NCT04049695
Influence of Reward and Punishment on Goal-directed and Habit Learning in Adolescent Anorexia Nervosa
NCT04051879
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NCT03703856
Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight
NCT04002440
Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC
NCT03646461
Sedentary Behavior Interrupted: A Trial of Acute Effects on Biomarkers of Healthy Aging
NCT03511352
Improving Postamputation Functioning by Decreasing Phantom Pain With Perioperative Continuous Peripheral Nerve Blocks: A Department of Defense Funded Multicenter Study
NCT03461120
Prior Axitinib as a Determinant of Outcome of Renal Surgery
NCT03438708
Effects of Negative Affect in Individuals With Binge Eating Episodes
NCT03393039
Brain Function in Adolescent Eating Disorders and Healthy Peers
NCT03347565
Southern California Nutrition Incentive Program
NCT02976389
Apremilast Pregnancy Exposure Registry
NCT02775500
OTIS Cimzia Pregnancy Registry
NCT01797224
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.